Opinion|Videos|June 28, 2024
Current Landscape of Biosimilar Use in US Healthcare Space
Dr Humphreys drives a conversation scoping the biosimilar landscape and available treatment options.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Provide an overview of the current landscape of FDA biosimilar approvals. What biosimilars are available? What trends are you seeing?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute
2
Bringing CAR T-Cell Therapy Into Community Cancer Centers
3
The True Cost of Running a Community CAR T-Cell Program
4
Higher Weight-Adjusted Waist Index Tied to CKD Mortality, Study Finds
5